Merck breaks ground on $3bn pharmaceutical manufacturing facility in Virginia
Merck has broken ground on a $3bn pharmaceutical manufacturing facility in Virginia. “Today is an important milestone for Merck, for
Read MoreMerck has broken ground on a $3bn pharmaceutical manufacturing facility in Virginia. “Today is an important milestone for Merck, for
Read MoreOfficially unveiled at the American Society of Human Genetics (ASHG) 2025 meeting held in Boston, Genomics has launched Mystra, an
Read MoreWANA (Oct 19) – The CEO of a leading Iranian knowledge-based pharmaceutical company announced the domestic production of Sirolimus —
Read MoreNovo Nordisk has appointed US pharmaceutical industry veteran Greg Meily as its new head of corporate affairs, as the obesity
Read MoreMerck KGaA, a German integrated science, pharmaceutical, and technology company with a significant market presence in the U.S., is the
Read MoreThe Greek government is requesting that the EU Council of Environment Ministers revise the Wastewater Management Directive (WWMD), warning that
Read MoreThe growing need for temperature-sensitive medicines like biologics, vaccines, and specialty drugs is driving the healthcare third-party logistics (3PL) market.
Read MoreNabla Bio announced a new multi-year research collaboration with Takeda aiming to advance AI-driven design of protein therapeutics. This collaboration
Read MoreA troubled Indiana contract manufacturing plant recently acquired by Novo Nordisk is considered to not be in compliance with the
Read MoreIn a recent panel discussion on supply chain security, Krenar Komoni, founder and CEO of Tive, emphasized the growing importance
Read More